Original ContributionReversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: Implications for Parkinson's disease
Introduction
Reduced glutathione (GSH) is a tripeptide consisting of glutamate, cysteine, and glycine. It is the most abundant nonprotein thiol within cells. GSH is synthesized by a two-step reaction involving the enzymes gamma-glutamylcysteine ligase (γ-GCL) and glutathione synthetase (GS). γ-GCL is the rate-limiting enzyme in this process [1]. GSH is present in high concentrations in both the mitochondrial and the cytosolic compartments of the cell. As mitochondria lack the enzymes for GSH synthesis, the mitochondrial GSH concentration is maintained via uptake from the cytosol [2]. GSH plays an important role in scavenging reactive oxygen and nitrogen species (ROS, RNS) and in recycling other antioxidants [3].
It has been observed that the substantia nigra (SN) of early PD patients displays a significant depletion of total glutathione levels [reduced glutathione (GSH) + oxidized glutathione (GSSG)] [4]. Glutathione depletion is the earliest reported biochemical change in the PD SN [5]. Decreases in glutathione availability in the brain promotes morphological mitochondrial damage most likely via increases in levels of oxidative or nitrosative stress in this organelle [6]. Although glutathione is not the only antioxidant molecule reported to be altered in PD, the magnitude of glutathione depletion appears to parallel the severity of the disease and is the earliest known indicator of nigral degeneration, reportedly preceding detectable losses in both mitochondrial complex I activity and striatal (ST) dopamine content [7]. Glutathione levels are not decreased in other areas of the PD brain nor in other diseases affecting dopaminergic SN neurons such as multiple system atrophy or progressive supranuclear palsy [4].
We previously demonstrated that acute glutathione depletion within both the cytosol and the mitochondria of cultured dopaminergic cells elicits a selective mitochondrial complex I inhibition resulting in mitochondrial dysfunction [8]. Complex I inhibition following acute glutathione depletion appeared to be via an NO-mediated event [9]. These results suggested that the early glutathione depletions observed in the Parkinsonian SN could be responsible for subsequent complex I inhibition, mitochondrial dysfunction, and neuronal cell loss. Earlier in vitro studies also have demonstrated that long-term exposure of mitochondrial membranes to nitric oxide (NO) resulted in selective and persistent inhibition of complex I activity via S-nitrosation of critical thiols in the enzyme complex. Furthermore, inhibition of complex I activity was reversible by addition of reduced glutathione, suggesting that GSH might protect complex I activity by preventing the S-nitrosation of critical thiol groups in the enzyme [10], [11]. Previous studies also demonstrated the importance of cellular antioxidant status, in particular the availability of reduced glutathione (GSH), in determining vulnerability of neurons to NO or peroxynitrite (PN) [12]. In this current study, we assess the effects of more prolonged glutathione depletion on mitochondrial function in dopaminergic cells to better emulate what occurs in PD. We report that following more prolonged glutathione depletion in vitro, CI inhibition is still reversible but appears to be a PN-mediated event which coincides with increased mitochondrial protein S-nitrosation.
Section snippets
Cell culture
N27 cells were grown in RPMI medium 1640 containing 10% fetal bovine serum, penicillin (100 units/ml), and streptomycin (100 μg/ml). The cells were differentiated with 2.0 mM dibutyryl adenosine 3′,5′-cyclic monophosphate (dbcAMP) and 60 μg/ml dehydroepiandrosterone (DHEA) for 2 days. Differentiating agents were added 24 h after plating [13]. Fresh media containing experimental compounds were added every 2–3 days. Cellular glutathione levels were chronically lowered via treatment of N27
Analysis of neuronal cell survival following chronic BSO treatment
To study the effects of chronic GSH depletion on dopaminergic neuronal survival, we first differentiated N27 cells using dbcAMP for 48 h [13]. After differentiation, the susceptibility of dopaminergic N27 cells to glutathione depletion was evaluated by performing MTT assays following 7 days of BSO (L-buthionine sulfoximine, an inhibitor of γ-glutamylcysteine ligase, GCL) exposure at concentrations ranging from 2.5 to 50 μM (Fig. 1). No significant cell death was observed up to a concentration
Discussion
Chronic dopaminergic glutathione depletion in vitro could result in similar effects on CI as those observed following acute glutathione depletion or it may result in alternative oxidative events such as irreversible protein nitration at tyrosine residues (3-nitrotyrosine (3-NT) adduct). To test this, we assessed the effects of more prolonged glutathione levels (7 days) on cell viability, glutathione levels, NO species, and CI activity. Interestingly, 7 day glutathione depletion assessed at a
Acknowledgments
This work was supported by NIH R01s AG12141 and NS045615 to J.K.A.
References (28)
Glutathione biosynthesis and its inhibition
Methods Enzymol.
(1995)Glutathione metabolism and its selective modification
J. Biol. Chem.
(1988)- et al.
Glutathione, iron and Parkinson's disease
Biochem. Pharmacol.
(2002) - et al.
Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients
Neurosci. Lett.
(1986) - et al.
Parkinson's disease: a disorder due to nigral glutathione deficiency?
Neurosci. Lett.
(1982) - et al.
Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease
J. Biol. Chem.
(2000) - et al.
Nitric oxide-mediated mitochondrial damage: a potential neuroprotective role for glutathione
Free Radic. Biol. Med.
(1996) - et al.
Convenient colorimetric and fluorometric assays for S-nitrosothiols
Anal. Biochem.
(1996) - et al.
Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines
Methods Enzymol.
(1996) - et al.
Formation of S- nitrosothiols via direct nucleophilic nitrosation of thiols by peroxynitrite with elimination of hydrogen peroxide
J. Biol. Chem.
(1998)
Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry
J. Biol. Chem.
Persistent S-nitrosation of complex I and other mitochondrial membrane proteins by S-nitrosothiols but not nitric oxide or peroxynitrite: Implications for the interaction of nitric oxide with mitochondria
J. Biol. Chem.
Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide
J. Biol. Chem.
Reversible glutathionylation of complex I increases mitochondrial superoxide formation
J. Biol. Chem.
Cited by (115)
In vitro/in vivo effects of some new 2,5-disubstituted 1,3,4-oxadiazole and hydrazone analogues targeting Parkinson's disease
2023, Journal of Molecular Structureα-synuclein aggregates induce c-Abl activation and dopaminergic neuronal loss by a feed-forward redox stress mechanism
2021, Progress in NeurobiologyRotenone neurotoxicity: Relevance to Parkinson's disease
2020, Advances in NeurotoxicologyNitric Oxide and Mitochondrial Function in Neurological Diseases
2018, Neuroscience